AVITA Medical (AVHHL) Receivables - Net (2018 - 2025)

AVITA Medical has reported Receivables - Net for 8 years, with the latest figure at $9.1 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables - Net fell 22.91% year-over-year to $9.1 million; the trailing twelve-month figure through Dec 2025 stood at $9.1 million (down 22.91% YoY), and the FY2025 full-year result was $9.1 million, down 22.91% from the prior year.
• Receivables - Net for Q4 2025 stood at $9.1 million, up from $9.0 million in the prior quarter.
• The five-year high for Receivables - Net was $12.0 million in Q1 2025, with the low at $2.2 million in Q1 2021.
• Historically, Receivables - Net has averaged $6.5 million across 5 years, with a median of $5.8 million in 2023.
• Annual changes were most pronounced in 2023 — Receivables - Net surged 118.04% — and 2025, when it declined 22.91%.
• AVITA Medical's Receivables - Net stood at $3.1 million in 2021, then increased by 12.73% to $3.5 million in 2022, then soared by 118.04% to $7.7 million in 2023, then surged by 53.78% to $11.8 million in 2024, then declined by 22.91% to $9.1 million in 2025.
• The last three Receivables - Net figures came in at $9.1 million (Q4 2025), $9.0 million (Q3 2025), and $11.3 million (Q2 2025), per Business Quant data.